Breaking News, Collaborations & Alliances

Clinigen CTS To Distribute Accord Drugs in EU

Agreement covers clinical trial distribution for Intas unit's injectable oncology portfolio

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Clinigen Clinical Trials Supply (Clinigen CTS) has entered an exclusive clinical trial distribution agreement with Accord Healthcare, the wholly-owned marketing subsidiary of India’s Intas Pharmaceuticals, covering the administration and distribution of Accord’s injectable cancer drugs across the EU. Clinigen CTS will act as the sole point of enquiry, order receipt and distribution of Accord products to manufacturers, CROs, clinical trial contract packagers and other specialist service provider...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters